A deadline of Feb. 29 is set for applicants seeking the Indiana Clinical and Translational Sciences Institute’s (CTSI) special post-doctoral training award in translational research. The award offers post-doctoral research associates at Indiana University, Purdue University and the University of Notre Dame experience in writing and reviewing proposals related to translational research — or the… Read more »
Tag: Intellectual property
IURTC personnel to speak about women inventors, IP valuation at AUTM meeting
Experts at Indiana University Research and Technology Corp. are organizing and will participate in discussions next week during the Association of University Technology Managers annual meeting Feb. 14 through 17 at the Manchester Grant Hyatt San Diego. AUTM is a global nonprofit organization dedicated to advancing technology transfer at institutes of higher learning. It has… Read more »
Concussion detection device developed by IU optometry professors recently featured in TV segment aired on Evansville's WFIE-14News
A portable device being developed by Indiana University optometry professors Nicholas Port and Steven Hitzeman to quickly detect concussion symptoms in athletes was featured this week on Evansville’s NBC affiliate, WFIE-14News. To measure concussion symptoms, Port and Hitzeman devised a system that includes eye-tracking goggles within a shoebox-sized device and a balance platform based on… Read more »
IURTC announces promotions in tech transfer, commercialization and general counsel
Officials at Indiana University Research and Technology Corp. have announced promotions for personnel in its technology transfer, commercialization and legal departments. Dave Wilhite has been named director of technology commercialization. He previously had been the assistant director. His duties include analyzing disclosed faculty inventions, managing the technology commercialization process, overseeing negotiations of licenses, administering outreach… Read more »
IUSM teams with Rose-Hulman Ventures to develop improved device for skin biopsies
Engineers at Rose-Hulman Ventures are working with surgeons and pathologists at the Indiana University School of Medicine on a biospy tool that may save lives by reducing how long it takes to detect skin cancer. The device involves using suction through a vacuum tube to produce uniform tissue depth for biopsies. At present, the inability… Read more »
IU ranked among world's 50 most innovative universities, based on patent, publishing data
According to a Reuters News analysis of patent and publishing data from hundreds of research institutions around the globe between 2008 and 2013, Indiana University ranks among the world’s 50 most innovative universities. IU placed 49th in the list of Top 100 World’s Most Innovative Universities and 33rd among U.S. universities. Twelve of the Top 100, including… Read more »
17th annual Mira Awards are just around the corner, with applications due by January 29
Applications now are being accepted for TechPoint’s 17th annual Mira Awards, which recognize Indiana’s top companies and individuals involved in technology innovation. For Hoosier entrepreneurs, the exposure and prestige offered by the Miras serves as a powerful springboard for their ventures. Past winners have reported securing $250,000 in new venture capital, signing $1 million in… Read more »
Biotech company with strong IU, Indiana ties adds execs ahead of anticipated clinical trials
Assembly Biosciences, a biotechnology company with strong Indiana University and Hoosier State ties that seeks to cure hepatitis B and C. difficile infections, announced several senior-level hires throughout the company on Monday. Founded in 2012, Assembly is largely built around the research of Adam Zlotnick, a professor of molecular and cellular biochemistry at Indiana University… Read more »
Article details IURTC's efforts to help bring an IU researcher's antibiotic derivative to market
Back in mid-2015, the Indiana University Research and Technology Corp. struck a deal with California-based La Jolla Pharmaceutical Co. to acquire intellectual property rights to “next-generation” offshoots of gentamicin — a hospital-grade antibiotic which has limited use because of its toxicity. Because the offshoots have shown signs of lacking such toxicity, they hold promise in… Read more »
Sideline diagnosis of concussions is the goal of two researchers at IU's School of Optometry
In a November 22 NFL game between the St. Louis Rams and the Baltimore Ravens, Rams quarterback Case Keenum was sacked in the fourth quarter and hit his head on the turf. Despite the Rams sending their head trainer on the field to talk with Keenum — and the presence of an NFL injury… Read more »